Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK

Jul-15

Endocrinology Healthcare Cost Pharmacoepidemiology

AUTHORS : Dr. William Valentine, Ossian Health Economics and Communications, Bäumleingasse 20, 4051 Basel, Switzerland – Email: valentine@ossianconsulting.com

JOURNAL : Diabetes Research and Clinical Practice

REFERENCE: 109(1):95-103

DOI : 10.1016/j.diabres.2015.04.023

Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study